Artivion, Inc. AORT 深滬

已收盤 01-30 16:00:00 美东时间

40.77

+0.350

+0.87%

華盛通

立即下載

最高41.25
今開40.53
成交量 61.37万股
最低 40.02
昨收 40.42
總市值 19.24亿
52周最高 48.25
市盈率 ^靜 --
換手率 1.30%
52周最低 21.97
委比 33.33%
總股本 4718.37万
歷史最高 48.25
量比 2.25
振幅 3.04%
歷史最低 3.82
每手 1
風險率 8.34%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Alphatec is the top performing healthcare equipment stock YTD

The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector a...

2025-12-23 01:12
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 10:22
Artivion Q3 Adj. EPS $0.16, Sales $113.388M Beat $110.437M Estimate

Artivion (NYSE:AORT) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.02 by 841.18 percent. This is a 33.33 percent increase over earnings of $0.12 per share from the same

2025-11-07 05:34
Artivion Treats First Patient In ARTIZEN Pivotal Study Evaluating Arcevo LSA Hybrid Stent Graft System For Acute, Chronic Arch Pathologies

Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the safety and

2025-11-06 21:36
美股大行评级 | 伯恩斯坦上调阿里巴巴目标价升至200美元；麦格理上调百度评级至"跑赢大市"，目标价升至176美元

今日重点评级关注：摩根大通：维持National Energy Services"超配"评级，目标价从10美元升至19美元；Piper Sandler：维持LENZ Therapeutics"超配"评级，目标价从51美元升至67美元

2025-10-13 11:26
JMP Securities Maintains Market Outperform on Artivion, Raises Price Target to $47

JMP Securities analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and raises the price target from $42 to $47.

2025-10-10 21:01
美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元

2025-09-30 14:16
Artivion To Acquire 1300 East Anderson Lane Property For $12.05M And 1200 East Anderson Lane Property For $8.45M

On September 26, 2025, Artivion, Inc. (the "Company") entered into two Real Estate Purchase and Sale Contracts having substantially similar material terms, except as noted otherwise herein. The first agreement is

2025-09-30 04:48

公司名稱	Artivion, Inc.
行業分類	Medical Specialties
業務描述	Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

派息除權日	每股總股息	派息日期
2015-12-09	0.03	2015-12-18
2015-09-09	0.03	2015-09-18
2015-06-10	0.03	2015-06-19
2015-03-11	0.03	2015-03-20
2014-12-10	0.03	2014-12-19
2014-09-10	0.03	2014-09-19
2014-06-11	0.03	2014-06-20
2014-03-12	0.03	2014-03-21
2013-12-11	0.03	2013-12-20
2013-09-11	0.03	2013-09-20
2013-06-12	0.03	2013-06-21
2013-03-12	0.03	2013-03-21
2012-12-12	0.03	2012-12-21
2012-09-12	0.03	2012-09-21

Artivion, Inc. AORT 深 滬

40.77

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Artivion, Inc. AORT 深滬